Abstract
Gustafsson D (AstraZeneca R&D, Mölndal, Sweden). Oral direct thrombin inhibitors in clinical development (Minisymposium). J Intern Med 2003; 254: 322–334. Thrombin has long been a target for...

This publication has 51 references indexed in Scilit: